THC BioMed Intl Ltd. (CSE: THC / OTC: THCBF / FSE: TFHC) – Ramping Up Sales of 2.0 Products / Trading at a 43% Discount
Highlights Generated $1.14M in revenue in Q1-FY2022 (quarter ended October 31, 2021), up 83% YoY,...
Read More
Company Name: THC BioMed Intl Ltd.
THC BioMed Intl Ltd. (CSE: THC / OTC: THCBF / FSE: TFHC) Transitioning to Cannabis 2.0 / Q1-FY2022 Critical
Highlights Generated $1.1M in revenue in Q3-FY2021 (quarter end April 30, 2021), up 24% YoY, and...
Read More
THC BioMed Intl Ltd. (CSE: THC / OTC: THCBF / FSE: TFHC) Adds Capacity for Edibles & Beverages
Highlights THC announced yesterday that it has completed construction of additional space for...
Read More
THC BioMed Intl Ltd. (CSE: THC / OTC: THCBF / FSE: TFHC)-Aiming to be a Leader in Cannabis Beverages and Edibles – Initiating Coverage
THC BioMed Intl Ltd. (“THC BioMed”, the “company”) is a cannabis 2.0 focused company positioning itself as a leader in beverages and edibles. The company’s two primary products at this point are the THC Kiss beverage shot, and THC Kiss gummies, both part of the THC Kiss product line.
Read More